Riskpilot← Back to searchSign inGet full accessModimed AB
ABActiveOrg 5567357321Diamantvägen 28General medical practice activities · NACE 8621Est. 20071 employees
Revenue 2025
SEK 610K
+122% vs 2024
EBITDA margin
65.2%
+765% vs 2024
Equity ratio
96.3%
Financial strength
Net profit 2025
SEK 376K
+667% vs 2024
| Revenue | SEK 610K | +122% |
| EBITDA | SEK 398K | +765% |
| Net profit | SEK 376K | +667% |
| Total assets | SEK 937K | +19% |
| Equity | SEK 902K | +24% |
| Employees | 1 | — |
Legal name
Modimed AB
Org number
5567357321
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
7 augusti 2007
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva medicinsk konsulting, utbildning och forskning i anslutning härtill, friskvård samt handel med värdepapper och därmed förenlig verksamhet.
Address
Diamantvägen 28
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 347 | 422 | 348 | 275 | 610 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −83 | 22 | 34 | 46 | 398 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −83 | 22 | 34 | 46 | 398 |
| Net financials | — | 228 | 1 | 2 | 1 |
| Profit before tax | −83 | 249 | 34 | 49 | 400 |
| Tax | −0 | −3 | −0 | −0 | −24 |
| Net profit | −83 | 246 | 34 | 49 | 376 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 050 | 1 116 | 950 | 787 | 937 |
| Equity | 959 | 1 026 | 873 | 727 | 902 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 91 | 91 | 77 | 60 | 35 |
| Total debt | 91 | 91 | 77 | 60 | 35 |
EBITDA margin
65.2%
This company
15.8%
Market median
+313% vs market
20212025
Equity ratio
96.3%
This company
38.2%
Market median
+152% vs market
20212025
Return on equity
41.7%
This company
18.4%
Market median
+127% vs market
20212025
Net profit margin
61.6%
This company
8.1%
Market median
+660% vs market
20212025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
20212025
Debt / equity
0.04×
This company
0.62×
Market median
+94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Modimed AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kjell Stefan Modin | Chairman | 0 companies |
| Marina Margareth Modin | Board of Directors | 0 companies |
| Albert Carl Johan Stefan Modin | Deputy Board Member | 0 companies |